HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Selvaggi Selected Research

Giovanni Selvaggi Research Topics

Disease

19Neoplasms (Cancer)
02/2024 - 06/2004
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 07/2002
7Lung Neoplasms (Lung Cancer)
01/2022 - 07/2003
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 06/2008
4Adenocarcinoma
05/2018 - 05/2002
3Fatigue
02/2024 - 03/2016
3Exanthema (Rash)
01/2022 - 01/2020
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2009 - 05/2002
2Disease Progression
02/2024 - 07/2003
2Diarrhea
02/2024 - 03/2016
2Brain Neoplasms (Brain Tumor)
11/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2020 - 12/2005
2Carcinoma (Carcinomatosis)
07/2003 - 05/2002
1Thymoma (Thymic Carcinoma)
02/2024
1Edema (Dropsy)
01/2023
1Hemorrhage
01/2022
1Leukopenia
01/2022
1Lymphopenia (Lymphocytopenia)
01/2022
1Neuroblastoma
11/2021
1Hyperbilirubinemia
01/2021
1Melanoma (Melanoma, Malignant)
01/2017
1Nausea
03/2016
1Myalgia
03/2016
1Anorexia
03/2016
1Febrile Neutropenia
03/2016
1Arthralgia (Joint Pain)
03/2016
1Neutropenia
03/2016
1Vomiting
03/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2015
1Malignant Mesothelioma
03/2010
1Hematologic Neoplasms (Hematological Malignancy)
01/2008
1Ovarian Neoplasms (Ovarian Cancer)
02/2006
1Rheumatoid Arthritis
02/2006
1Parasitic Diseases (Parasitic Disease)
02/2006
1Mesothelioma
02/2006
1Large Cell Carcinoma
05/2002

Drug/Important Bio-Agent (IBA)

6ensartinibIBA
02/2024 - 01/2020
6NivolumabIBA
02/2024 - 01/2018
6PlatinumIBA
01/2021 - 07/2003
5Anaplastic Lymphoma KinaseIBA
02/2024 - 01/2021
4Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2002
4CrizotinibIBA
02/2024 - 01/2020
4Alanine Transaminase (SGPT)IBA
02/2024 - 01/2020
4GemcitabineFDA Link
05/2018 - 07/2003
4Carboplatin (JM8)FDA LinkGeneric
01/2017 - 01/2005
4Pemetrexed (MTA)FDA Link
03/2010 - 01/2005
3Immune Checkpoint InhibitorsIBA
02/2024 - 01/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 05/2006
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2024 - 01/2020
3IpilimumabIBA
01/2021 - 01/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 11/2009
3ErbB Receptors (EGF Receptor)IBA
03/2016 - 06/2004
3Thymidylate SynthaseIBA
03/2010 - 02/2006
2Tyrosine Kinase InhibitorsIBA
02/2024 - 11/2021
2vorolanibIBA
02/2024 - 01/2022
2Folic Acid AntagonistsIBA
01/2008 - 02/2006
1Programmed Cell Death 1 ReceptorIBA
02/2024
1Platelet-Derived Growth FactorIBA
02/2024
1cyclopropapyrroloindoleIBA
01/2022
1pembrolizumabIBA
01/2022
1Circulating Tumor DNAIBA
01/2021
1alectinibIBA
01/2021
1AmylasesFDA Link
01/2020
1TransferasesIBA
01/2020
1SteroidsIBA
01/2020
1ceritinibIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Lipase (Acid Lipase)FDA Link
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1ElectrolytesIBA
03/2016
1Caspase 3 (Caspase-3)IBA
07/2015
1Bevacizumab (Avastin)FDA Link
11/2009
1Gefitinib (Iressa)FDA Link
11/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2009
1Etoposide (VP 16)FDA LinkGeneric
06/2008
1Proteinase-Activated ReceptorsIBA
05/2006
1AntibodiesIBA
05/2006
1raltitrexed (D 1694)IBA
02/2006
1AntimetabolitesIBA
02/2006
1Diphosphonates (Bisphosphonates)IBA
12/2005
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2005
1NucleotidesIBA
06/2004
1Cisplatin (Platino)FDA LinkGeneric
07/2003
1Biotin (Vitamin H)FDA Link
05/2002
1AvidinIBA
05/2002

Therapy/Procedure

11Drug Therapy (Chemotherapy)
02/2024 - 07/2002
9Therapeutics
01/2021 - 06/2004
1Activities of Daily Living (ADL)
10/2005
1Induction Chemotherapy
07/2003